Clinical Trials on ATL

Total 432374 results

Duke University
Smith & Nephew, Inc.

Completed

Transphyseal Vs. Physeal Sparing ACL Reconstruction in Skeletally Immature Patients: Risk of Subsequent Lower Extremity Growth Deformity

ACL Reconstruction

United States
Daiichi Sankyo Co., Ltd.

Completed

Phase 1 Study of Quizartinib

Relapsed AML | Refractory AML

Japan
Carbiogene Therapeutics Co. Ltd.
Zhejiang Provincial People's Hospital

Recruiting

Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

AML M5 | AML M4

China
DKMS gemeinnützige GmbH

Active, not recruiting

Haploidentical Donor vs mMUD in Hematological Malignancies (HAMLET)

AML | MDS | ALL

Germany
Zhejiang University

Not yet recruiting

Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML

AML

China
Zhejiang University

Not yet recruiting

Evaluate the Safety and Efficacy of CLL1 CAR-T in Patients With R/R AML

AML

China
Zhejiang University

Not yet recruiting

Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML

AML

China
Zhejiang University

Not yet recruiting

Evaluate the Safety and Efficacy of ADGRE2 CAR-T in Patients With R/R AML

AML

China
Aptevo Therapeutics

Withdrawn

Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML

AML
Martin-Luther-Universität Halle-Wittenberg

Unknown

Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible (TCP-AML)

AML

Germany
Nantes University Hospital

Completed

High-Dose Imatinib for Relapsed/Refractory c-Kit Positive Acute Myelogenous Leukemia (AML)

AML

France
PETHEMA Foundation

Recruiting

Epidemiologic Registry PETHEMA LMA 2015

AML

Spain
Hospital Universitario Dr. Jose E. Gonzalez

Completed

Low-dose Venetoclax and Azacitidine as Front-line Therapy in Newly Diagnosed AML

AML

Mexico
Rambam Health Care Campus

Unknown

Rapid Profiling of Bone Marrow, at Presentation and After 5 Days of Induction Therapy

AML

Israel
University of Birmingham

Completed

A Study Evaluating the Safety and Activity of Pegylated Recombinant Human Arginase (BCT-100) (PARC)

Cancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AML

United Kingdom, Australia, Netherlands
Zhejiang University
Hangzhou Cheetah Cell Therapeutics Co., Ltd

Recruiting

NKG2D CAR-NK & r/rAML

AML

China
Beijing Immunochina Medical Science & Technology...

Not yet recruiting

Donor-derived CAR-T Cells in the Treatment of AML Patients

AML

China
Zhejiang University
Shanghai Zeke Biotechnology Co.，Ltd

Terminated

NK Cell Therapy for AML

AML

China
PETHEMA Foundation

Completed

Epidemiologic Registry PETHEMA LMA 2013

AML

Spain
Seattle Children's Hospital
Children's Healthcare of Atlanta; Pediatric Oncology Experimental Therapeutics...

Completed

POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

AML | Acute Leukemia of Ambiguous Lineage | ALL | Relapsed/Refractory AML | Relapsed/Refractory ALL | Secondary AML/MDS

United States, Canada
Stichting Hemato-Oncologie voor Volwassenen Nederland

Recruiting

A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML (HO171)

AML, Adult

Netherlands
NYU Langone Health

Completed

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction

ACL

United States
Therapeutic Advances in Childhood Leukemia Consortium
Bristol-Myers Squibb

Active, not recruiting

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

AML, Childhood

United States
OPKO Health, Inc.

Completed

Efficacy and Tolerability of a Nutritional Supplement, Plactive Progen, in ACL Reconstruction

ACL Reconstruction
ETH Zurich
University of Zurich

Not yet recruiting

Pharmacoscopy-guided Clinical Standard-of-care in r/r AML (RAPID-01)

AML, Adult
Zhejiang University
Hangzhou Qihan Biotech Co.,Ltd.

Recruiting

Natural Killer(NK) Cell Therapy in r/r AML

AML, Adult

China
BioNova Pharmaceuticals (Shanghai) LTD.

Recruiting

A Study of BN104 in the Treatment of Acute Leukemia

AML, Adult | ALL, Adult

China
Zhejiang University
Hangzhou Qihangene Biotech Co.,Ltd.

Recruiting

Natural Killer(NK) Cell Therapy Targeting CLL1 in Acute Myeloid Leukemia

AML, Adult

China
Gruppo Italiano Malattie EMatologiche dell'Adulto

Recruiting

Novel Approaches to Target MECOM/EVI1 in AML

AML, Adult

Italy
BioSight Ltd.

Recruiting

A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagnosed AML

AML, Adult

United States
PETHEMA Foundation

Terminated

LENA-LMA-5:Lenalidomide in Acute Myeloid Leukemia (AML)

AML

Spain
Shanghai General Hospital, Shanghai Jiao Tong University...

Recruiting

CLL-1 CAR-NK Cells for Relapsed/Refractory AML

Relapsed Adult AML | Refractory AML

China
Apollomics Inc.
Zhejiang CrownMab Biotech Co. Ltd

Recruiting

Study to Evaluate PK and Safety With Uproleselan Combined With Chemotherapy to Treat Chinese R/R AML Patients

Relapsed/Refractory AML

China
Fujian Medical University

Recruiting

Comparing the Consolidation Regimens of IDA With Intermediate-dose Cytarabine Versus Intermediate-dose Cytarabine Alone for Elderly AML Patients

AML in Remission

China
Mayo Clinic
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Recruiting

Neuromuscular Intervention Targeted to Mechanisms of ACL Load in Female Athletes

Rehabilitation | ACL Reconstruction

United States
Fujian Medical University

Unknown

CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001)

Relapsed/Refractory AML

China
University Hospital, Grenoble
French Innovative Leukemia Organisation; BGMT

Completed

Treatment Outcome in Elderly Patients

AML | Elderly Patients

France
Mostafa Hassanein, Msc

Completed

Patients With Acl Injury and Varus Knee Will Undergo Acl Reconstruction Alone, or Combined With High Tibial Osteotomy in the Same Session.

ACL Injury | Knee Deformity | ACL - Anterior Cruciate Ligament Deficiency | Varus Deformity of Tibia (Disorder)

Egypt
Apollomics Inc.
Zhejiang CrownMab Biotech Co. Ltd

Recruiting

Study to Evaluate the Efficacy of Uproleselan in Combination With Chemotherapy in Chinese Patients With R/R AML

Relapsed/Refractory AML

China
Pacira CryoTech, Inc., a wholly owned subsidiary...

Withdrawn

Evaluate the Iovera° Device in Treating Pain Associated With Anterior Cruciate Ligament Reconstruction

ACL Reconstruction
Clavis Pharma
Syneos Health; Theradex; CardiaBase; Learn & Confirm

Completed

The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055)

Relapsed/Refractory AML

United Kingdom, Spain
Centre of Postgraduate Medical Education

Recruiting

ACL Reconstruction With/Without ALL Reconstruction

ACL Injury | ALL

Poland
Chen Suning

Recruiting

Venetoclax + Decitabine vs. "7+3" Induction Chemotherapy in Young AML

Chemotherapy Effect | AML, Adult

China
Institute of Hematology & Blood Diseases Hospital

Unknown

Efficacy and Safety of Chidamide in CBF Leukemia

AML

China
Sanford Health

Terminated

Playmaker 3D Printed Knee Extender

ACL | ACL Injury

United States
The First Hospital of Jilin University

Active, not recruiting

Plerixafor Plus Donor Lymphocyte Infusion for Relapsed Acute Leukemia After Allo-HSCT

Relapsed Adult AML | Relapsed Adult ALL

China
Istituto Ortopedico Rizzoli

Active, not recruiting

Evaluation Of Clinical Results And Imaging Of Anterior Cruciate Ligament Reconstruction With Orthopure Xt

ACL | ACL Injury

Italy
University of Wisconsin, Madison

Recruiting

Mindfulness and ACL Surgery

ACL | ACL Injury

United States
Universidad de Granada
Hospital Vithas

Active, not recruiting

Comparison of Semitendinosus and Quadriceps Grafts for Anterior Cruciate Ligament Reconstruction

ACL | ACL Injury

Spain
Vanderbilt University Medical Center
The Cleveland Clinic

Completed

Improving ACL Reconstruction Outcomes: CBPT

ACL Injury | ACL Tear | ACL - Anterior Cruciate Ligament Rupture | ACL Sprain

United States

Clinical Trials on ATL

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations